EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank57
3Y CAGR-39.4%
5Y CAGR-33.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-39.4%/yr
vs +1.6%/yr prior
5Y CAGR
-33.7%/yr
Recent deceleration
Acceleration
-41.0pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.06 | +9.3% |
| 2024 | 0.05 | +278.2% |
| 2023 | 0.01 | -94.6% |
| 2022 | 0.26 | +72.6% |
| 2021 | 0.15 | -66.7% |
| 2020 | 0.45 | -35.5% |
| 2019 | 0.69 | +187.1% |
| 2018 | 0.24 | -73.9% |
| 2017 | 0.93 | - |
| 2016 | 0.00 | - |